AI models tested to predict lung disease in preterm infants
NCT ID NCT07525167
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether artificial intelligence (AI) tools like ChatGPT, Gemini, and Claude can predict bronchopulmonary dysplasia (a serious lung condition) in premature babies. Researchers will use medical records from the first three weeks of life for 108 infants born before 32 weeks or weighing under 1,500 grams. No treatments are given—the goal is simply to see how well the AI models can forecast the disease compared to actual outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that AI can help doctors identify high-risk preterm infants earlier, potentially leading to better monitoring and care.
What could go wrong
This is a small, early-stage observational study with no treatment tested. The AI predictions may not be accurate enough for real-world use, and results may not apply to other hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Konya City Hospital, İstiklal, Adana Çevre Yolu Cd. No:135/1
Konya, 42020, Turkey (Türkiye)